{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:31:19Z","timestamp":1791851479247,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Donor-derived cell-free DNA (dd-cfDNA) is a marker of the presence and severity of injury in kidney transplant recipients (KTRs). The impact of early elevations in dd-cfDNA on long-term outcomes remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We included all KTR from February 2019 to March 2022 with dd-cfDNA (AlloSure) surveillance and without rejection or graft failure in the first 90 d posttransplant. Participants were stratified into groups based on the highest dd-cfDNA in the first 90 d: &lt;0.5%, 0.5% to &lt;1%, or \u22651%. Outcomes included graft dysfunction (estimated glomerular filtration rate &lt;45\u2009mL\/min), de novo donor-specific antibodies, biopsy-proven acute rejection, death, and graft failure, over the following 2 y.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      A total of 255 KTR were analyzed. Sixty (23.5%) had their highest dd-cfDNA result between 0.5% and 1%, and 16 (6.3%) were \u22651.0%. Participants with elevated dd-cfDNA had significantly lower freedom from rejection (&lt;0.5% = 94.0%, 0.5% to &lt;1% = 86.2%, \u22651% = 66.7%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001) and trended toward lower freedom from graft dysfunction (&lt;0.5% = 54.9%, 0.5% to &lt;1% = 49.2%, \u22651% = 31.3%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.122) over the subsequent 2 y. The hazard ratio of a step up between 2 of the 3 groups was 2.12 (95% confidence interval, 1.18-3.81;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.01) for rejection and 1.17 (95% confidence interval, 0.88-1.56;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.29) for graft dysfunction. The groups had similar freedom from de novo donor-specific antibody, graft failure, or death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our data demonstrate that early elevations in dd-cfDNA are associated with an increased risk of rejection and lower estimated glomerular filtration rate in KTR. As dd-cfDNA is a leading indicator of injury, surveillance may add prognostic value beyond biopsy alone and identify patients at risk who warrant closer monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001905","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:01:31Z","timestamp":1768932091000},"page":"e1905","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Early Elevations in Donor-derived Cell-free DNA are Associated With Increased Risk of Future Rejection and Graft Dysfunction After Kidney Transplant"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-7465","authenticated-orcid":false,"given":"Sandesh","family":"Parajuli","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Zona","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetika","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree","family":"Patel","sequence":"additional","affiliation":[{"name":"CareDx, Inc, Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pinney","sequence":"additional","affiliation":[{"name":"CareDx, Inc, Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier A.","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"R1-20260123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1681\/ASN.2017010004","article-title":"Precision transplant medicine: biomarkers to the rescue.","volume":"29","author":"Naesens","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R2-20260123","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R3-20260123","doi-asserted-by":"crossref","first-page":"e14436","DOI":"10.1111\/ctr.14436","article-title":"Transplant kidney biopsy for proteinuria with stable creatinine: findings and outcomes.","volume":"35","author":"Parajuli","year":"2021","journal-title":"Clin Transplant"},{"key":"R4-20260123","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/ajt.14466","article-title":"Utility of protocol kidney biopsies for de novo donor-specific antibodies.","volume":"17","author":"Parajuli","year":"2017","journal-title":"Am J Transplant"},{"key":"R5-20260123","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection.","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"R6-20260123","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.3389\/ti.2022.10448","article-title":"Donor derived cell free DNA in kidney transplantation: the Circa 2020-2021 update.","volume":"35","author":"Kant","year":"2022","journal-title":"Transpl Int"},{"key":"R7-20260123","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0272-6386(87)80042-2","article-title":"The plasma creatinine concentration is not an accurate reflection of the glomerular filtration rate in stable renal transplant patients receiving cyclosporine.","volume":"10","author":"Ross","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"R8-20260123","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts.","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R9-20260123","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1373\/clinchem.2008.113597","article-title":"Profile of the circulating DNA in apparently healthy individuals.","volume":"55","author":"Beck","year":"2009","journal-title":"Clin Chem"},{"key":"R10-20260123","doi-asserted-by":"crossref","first-page":"100649","DOI":"10.1016\/j.trre.2021.100649","article-title":"The clinical value of donor-derived cell-free DNA measurements in kidney transplantation.","volume":"35","author":"Garg","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"R11-20260123","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1373\/clinchem.2013.210328","article-title":"Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury.","volume":"59","author":"Beck","year":"2013","journal-title":"Clin Chem"},{"key":"R12-20260123","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/tri.13341","article-title":"Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study.","volume":"32","author":"Shen","year":"2019","journal-title":"Transpl Int"},{"key":"R13-20260123","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.transproceed.2015.08.035","article-title":"Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation.","volume":"47","author":"Beck","year":"2015","journal-title":"Transplant Proc"},{"key":"R14-20260123","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"R15-20260123","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","article-title":"Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients.","volume":"4","author":"Jordan","year":"2018","journal-title":"Transplant Direct"},{"key":"R16-20260123","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fimmu.2020.01392","article-title":"Solid organ transplantation during the COVID-19 pandemic.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"R17-20260123","doi-asserted-by":"crossref","first-page":"e70019","DOI":"10.1111\/ctr.70019","article-title":"Changes in donor-derived cell-free DNA before and after rejection and de novo DSA detection in primary and repeat kidney transplant recipients.","volume":"38","author":"Parajuli","year":"2024","journal-title":"Clin Transplant"},{"key":"R18-20260123","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients.","volume":"18","author":"Grskovic","year":"2016","journal-title":"J Mol Diagn"},{"key":"R19-20260123","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/TP.0000000000002566","article-title":"Subclinical antibody-mediated rejection after kidney transplantation: treatment outcomes.","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R20-20260123","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5500\/wjt.v9.i6.123","article-title":"Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression.","volume":"9","author":"Parajuli","year":"2019","journal-title":"World J Transplant"},{"key":"R21-20260123","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12895","article-title":"Outcomes in the highest panel reactive antibody recipients of deceased donor kidneys under the new kidney allocation system.","volume":"31","author":"Parajuli","year":"2017","journal-title":"Clin Transplant"},{"key":"R22-20260123","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ndt\/gfad120","article-title":"Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function.","volume":"39","author":"Cucchiari","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R23-20260123","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/TP.0000000000004078","article-title":"A novel high-throughput droplet digital PCR-based indel quantification method for the detection of circulating donor-derived cell-free DNA after kidney transplantation.","volume":"106","author":"Verhoeven","year":"2022","journal-title":"Transplantation"},{"key":"R24-20260123","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4285\/kjt.20.0053","article-title":"Serum creatinine level at 1-month posttransplant can independently predict long-term graft survival and functional status.","volume":"34","author":"Koh","year":"2020","journal-title":"Korean J Transplant"},{"key":"R25-20260123","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival.","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"R26-20260123","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1097\/01.tp.0000700384.55493.3b","article-title":"Proteinuria at 1 year after kidney transplantation and long-term graft survival.","volume":"104","author":"Kim","year":"2020","journal-title":"Transplantation"},{"key":"R27-20260123","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/FTD.0000000000000593","article-title":"Tacrolimus trough level at the first month may predict renal transplantation outcomes among living Chinese kidney transplant patients: a propensity score-matched analysis.","volume":"41","author":"Yin","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R28-20260123","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/tri.13932","article-title":"Post-kidney transplant serum magnesium exhibits a U-shaped association with subsequent mortality: an observational cohort study.","volume":"34","author":"Panthofer","year":"2021","journal-title":"Transpl Int"},{"key":"R29-20260123","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ekir.2020.12.038","article-title":"Early posttransplant blood transfusion and risk for worse graft outcomes.","volume":"6","author":"Daloul","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R30-20260123","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ckj\/sfaa061","article-title":"Calcium and phosphate levels after kidney transplantation and long-term patient and allograft survival.","volume":"14","author":"Chevarria","year":"2020","journal-title":"Clin Kidney J"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:00:33Z","timestamp":1769184033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001905","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}